Autopsy report · NCT00435578
Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma
Cause of deathNo reason given
Life of this trial
- Ran for about 9 months before it stopped.
- 50 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Threshold Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Carcinoma, Small Cell Lung
- Interventions
- Glufosfamide
- Participants
- 50 (planned, not actual)
- Sites
- 3
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.